[Chromosomal Aberrations in Myelodysplastic Syndromes]

Area of Science:

• Hematology
• Genetics
• Oncology

Background:

• Myelodysplastic syndromes (MDS) are clonal hematopoietic disorders.
• MDS are characterized by ineffective hematopoiesis, peripheral blood cytopenias, and a high risk of transformation to acute myeloid leukemia.
• Chromosomal aberrations are frequent in MDS and are critical for diagnosis and prognosis.

Purpose of the Study:

• To review the types of chromosomal aberrations found in MDS.
• To summarize the clinical significance of these aberrations for diagnosis and prognosis.
• To highlight the prognostic implications of different aberration types, including balanced translocations.

Main Methods:

• Literature review of chromosomal aberrations in myelodysplastic syndromes.
• Analysis of the role of chromosomal abnormalities in MDS pathogenesis.
• Evaluation of the diagnostic and prognostic value of chromosomal aberrations.

Main Results:

• Approximately 50% of MDS patients exhibit chromosomal abnormalities, predominantly unbalanced aberrations.
• Different types of chromosomal aberrations correlate with distinct clinical outcomes.
• Balanced chromosomal translocations, though less common, are associated with a higher rate of leukemia transformation.

Conclusions:

• Chromosomal aberrations are key features of MDS with significant diagnostic and prognostic implications.
• Understanding the specific chromosomal abnormalities aids in predicting disease progression and patient outcomes.
• Further research into the role of balanced translocations in MDS transformation is warranted.